Therefore, the observed association between oxytocin exposure and neonatal hyperbilirubinemia in our study is more plausibly explained by indirect mechanisms, such as altered uteroplacental perfusion, transient fetal hypoxia, or secondary effects on bilirubin metabolism, rather than direct fetal exposure to oxytocin. This evidence concerns the gene OXT and Hyperbilirubinemia.